LakeShore Biopharma Co Ltd (LSB)
0.60
+0.02
(+2.56%)
USD |
NASDAQ |
Jun 21, 16:00
0.6059
+0.01
(+0.98%)
After-Hours: 20:00
LakeShore Biopharma Total Assets (Quarterly): 220.84M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 220.84M |
| June 30, 2023 | 232.96M |
| Date | Value |
|---|---|
| September 30, 2022 | 217.29M |
| March 31, 2022 | 226.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
217.29M
Minimum
Sep 2022
232.96M
Maximum
Jun 2023
224.47M
Average
223.81M
Median
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 58.01M |
| Zai Lab Ltd | 988.44M |
| China SXT Pharmaceuticals Inc | 14.59M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 144.48M |
| Shareholders Equity (Quarterly) | 76.35M |
| Debt to Equity Ratio | 0.9778 |
| Current Ratio | 1.409 |
| Net Debt Paydown Yield | -10.09% |